Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results

The objective of this study was to assess the frequency of comorbidities and multimorbidities in rheumatoid arthritis (RA) patients under biologic therapy and their effects on biological disease modifying antirheumatic drugs (DMARDs) choice, timing, and response. Hacettepe University Biologic Regist...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Armagan, Berkan, Sari, Alper, Erden, Abdulsamet, Kilic, Levent, Erdat, Efe Cem, Kilickap, Saadettin, Kiraz, Sedat, Bilgen, Sule Apras, Karadag, Omer, Akdogan, Ali, Ertenli, Ihsan, Kalyoncu, Umut
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2018
Assuntos:
6900
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5895384/
https://ncbi.nlm.nih.gov/pubmed/29595700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000009930
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados